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Abstract  
AIM: The basic aim of this study was to discover the association of End Stage Renal Disease 
(ESRD) with various risk factors. End Stage Renal Failure is the last stage of the chronic renal 
failure in which kidneys become completely fail to function.  
MATERIALS AND METHODS: The data were collected from the patients of renal diseases from 
three major hospitals in Peshawar, Pakistan. Odds ratio analysis was performed to examine the 
relationship of ESRD (a binary response variable) with various risk factors: Gender, Diabetic, 
Hypertension, Glomerulonephritis, Obstructive Nephropathy, Polycystic kidney disease, Myeloma, 
SLE Nephritis, Heredity, Hepatitis, Excess use of Drugs, heart problem and Anemia.  
RESULTS: Using odds ratio analysis, the authors found that the ESRD in diabetic patients was 
11.04 times more than non-diabetic patients and the ESRD were 7.29 times less in non-
hypertensive patients as compared to hypertensive patients. Similarly, glomerulonephritis patients 
had 3.115 times more risk of having ESRD than non-glomerulonephritis. Other risk factors may 
also, to some extent, were causes of ESRD but turned out insignificant due to stochastic sample.  
CONCLUSION: The authors concluded that there is a strong association between ESRD and three 
risk factors, namely diabetes, hypertension and glomerulonephritis. 
 
 
 
 
 
Introduction 
 
Statistical methods are applied frequently in 
medical research, which deals with issues that are of 
great concern for the general public. It is now a well-
known fact that no research could be carried out 
without having sufficient knowledge of Statistics. 
Particularly, medical research requires a good 
understanding of statistical methods.  
End Stage Renal Disease (ESRD) is the last 
stage of the chronic renal failure in which kidneys fail 
to function completely. At this stage, the kidney stops 
its functions to remove the impurities and control 
electrolytes. The symptoms of ESRD comprise less 
urine output, swelling of legs, face, nausea and 
vomiting [1].  
ESRD is one of the major health problems 
throughout the world. Several investigations have 
been carried out to study various risk factors of the 
ESRD. The United States Renal Data System 
(USRDS) established in 1989. This system is the 
largest and most comprehensive national Chronic 
Kidney Disease (CKD) and ESRD surveillance system 
[2]. The death rate due to ESRD in western countries 
especially in the USA is higher, but in Asian countries 
like Pakistan, India, Bangladesh; there are also a 
significant number of deaths due to ESRD [3]. 
It has been established that both low 
estimated Glomerular Filtration Rate (eGFR) and high 
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albuminuria were independently associated with 
mortality and ESRD regardless of age across a wide 
range of populations [4]. A retrospective cross-
sectional study was conducted to investigate the 
prevalence and associated comorbidities of Stage 3 
(GFR 30-59 ml/min/1.73 m^2) and Stages 4 and 5 
(GFR <30 mL/min/1.73 m^2) CKD among Chinese 
nursing home older adults. The researchers 
concluded that stages 3 to 5 CKD are widespread in 
Chinese nursing home older adults [5]. Regardless of 
higher risks of mortality and ESRD in diabetes, the 
relative risks of these outcomes by eGFR and 
Albumin-to-Creatinine Ratio (ACR) are much the 
same irrespective of the presence or absence of 
diabetes, highlighting the significance of kidney 
disease as a predictor of clinical outcomes [6]. 
It has been recognized that males and 
females face increased risk of all-cause mortality, 
cardiovascular mortality, and ESRD with lower 
estimated GFR and higher albuminuria [7]. It has been 
shown that declines in estimated GFR smaller than a 
doubling of serum creatinine concentration occurred 
more commonly and were strongly and consistently 
associated with the risk of ESRD and mortality, 
supporting consideration of lesser declines in 
estimated GFR (such as a 30% reduction over 2 
years) as an alternative end point for CKD 
development [8]. A kidney failure definition, including 
treated and untreated disease identifies more cases 
than linkage to the United States Renal Data System 
registry alone, particularly among older adults [9]. It 
has been found that CKD is increasingly common in 
older adults. Competing risks of death influence the 
risk of development to ESRD [10]. 
By using survival analysis through the Cox 
proportional hazard model, the researchers found that 
the elevated C - reactive protein (CRP) was a robust 
predictor of mortality in ESRD patients. In a study of 
663 ESRD patients (374 males and 289 females), the 
researchers also found that CRP was a strong 
predictor. CRP had positive correlation (= 0.369; p-
value equal to 0.001) in addition, the coefficient of 
correlation for females (= 0.519; p-value < 0.0001) 
and male correlation (= 0.372; p-value < 0.0001) [11]. 
A univariate Cox regression analysis was 
carried out and the researchers found that the 
chlamydia pneumonia infection was related to the 
cardiovascular risk of ESRD patients. In a cohort of 
227 ESRD patients, the Hazard Ratio of mortality was 
1.08 with 95% confidence interval (0.678 to 1.722); p-
value = 0.737. The researchers concluded that the 
chlamydia pneumonia infection is a major risk factor in 
patients with ESRD [12]. 
In a prospective cohort study of 143802 
patients in China, having an age of 40 years or above, 
the researchers found that the Body Mass Index (BMI) 
is strongly associated with ESRD. The multivariate-
adjusted risks for ESRD are 1.389 with 95% 
confidence interval (1.021 to 1.909) for BMI < 18.52 
kg/m, 1.213 with 95% confidence interval (0.919 to 
1.598) for BMI (25.01 to 29.93 kg/m) and 2.142 with 
confidence interval 95% (1.392 to 3.289) for BMI ≥ 
30.01 kg/m with J-shaped association [13]. A cohort 
study was carried out in survival analysis and the 
researchers concluded that the independent risk 
factors of ESRD are sex, race, anemia and heredity 
[14]. 
In this study, odds ratio analysis was used to 
examine the relationship of ESRD with various risk 
factors. 
 
 
Materials and Methods 
 
To determine the effects of various risk 
factors on ESRD, this study was carried out based on 
the data obtained from three major hospitals in 
Peshawar: (i) Hayatabad Medical Complex, (ii) Lady 
Reading Hospital and (iii) Khyber Teaching Hospital. 
The association of various risk factors with the 
occurrence of ESRD was determined through the 
statistical technique of odds ratio analysis. A total of 
407 patients was examined for the presence or 
absence of ESRD. The statistical analyses were 
performed with SPSS software package.  
Odds and the odds ratio: The probability of 
interested events divided by the probability of non-
interested events are called the Odds, i.e. Odd = P/1-
P, where P is the probability of interested events. If 
the observed dichotomous data contain ‘X’ number of 
interested events in ‘n' outcomes, then the odds ratio 
of interest can be calculated as:  
Odds =  . 
‘X’ denotes the number of occurrences of interested 
events and ‘n-X' indicates the number of non-
interested events. 
In order to compare two binary data sets, the 
ratio of odds of interest in one set to the odds of the 
other data set, is a relative measure of odds of 
interest. The odds ratio is denoted by  , and 
mathematically, it is defined as: 
 
If the probability of interest in two data sets is 
equal, then the odds ratio (Ψ) = 1 and if odd ratio (Ψ) 
< 1, then the odds of interest will be less in the first 
data set than in the second one. On the other hand, if 
the odds ratio (Ψ) > 1, then the odds of an interest will 
be greater in the first data set [15]. 
Statistical inference based on odds ratio: 
To estimate the odds ratio, the binary data are needed 
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to arrange in (2x2) contingency table given as:  
Contingency Table 
 
No. of 
Success 
No. of Failure  Total 
Data Set 1  A  B  a+b 
Data Set 2  C  D  c+d 
Total  a+c  b+d  N 
 
The probabilities of interest obtained from two 
data sets are 
ba
a
P

1
ˆ  and
dc
c
P

2
ˆ . The 
estimated odds ratio ( ) is given by: 
bc
ad
PP
PP




)ˆ1(ˆ
)ˆ1ˆ
ˆ
22
11  
This estimated odds ratio (ˆ ) is usually 
termed as “cross-product ratio”, as it is obtained by 
multiplying the two pairs of diagonal values in the (2 x 
2) contingency table [16]. 
 To test such an association, the hypothesis is 
considered as: 
1:0 H  or equivalently, 0)ln(:0 H , means 
that the two variables (ESRD and Risk factors) are 
independent, that is, risk factors do not affect ESRD. 
 The test-statistic is: 
 )ˆln(.
)ˆln(


ES
Z  , which 
has an approximate standard normal distribution. An 
approximate 100 (1- α) % confidence interval for 
)ln( is constructed as: 
 )ˆln(.)ˆln( 2/   ESZ  . (I)    
For example, a 95% confidence interval for )ln( is 
given by 
    )ˆln(.96.1)ˆln(  ES . 
The confidence interval given by equation (I) on 
inversion will give us the confidence interval for ψ as: 
ESzESz ee .2/.2/ ˆˆ    .  
If the interval contains unity, it indicates 
independence; otherwise an association between risk 
factor and ESRD is significant. 
 
 
Results 
 
Several researchers have investigated the 
association of ESRD and its various risk factors. A 
meta-analysis study was conducted. The 
interpretation of this study was that CKD should be 
regarded as at least an equally relevant risk factor for 
mortality. These researchers further interpreted that 
ESRD in individuals without hypertension should be 
regarded as it is in those with hypertension [17]. It has 
been revealed that diabetes, higher systolic blood 
pressure, lower estimated glomerular filtration rate 
and black race were risk factors for developing treated 
chronic kidney failure irrespective of albuminuria 
status, although the absolute risk of kidney failure in 
participants without albuminuria was very low. These 
researcher also showed that their findings support 
testing for kidney disease in high-risk populations, 
which often have otherwise unrecognized kidney 
disease [18]. 
To investigate the relationship of ESRD with 
various risk factors, we used odds ratio analysis. 
 
ESRD versus gender 
Contingency table of ESRD versus gender is 
given in Table (1). The calculated values are: Odd 
Ratio = 1.40, Chi-square = 2.628, p-value = 0.105 and 
the confidence interval is (0.931, 2.104).  
Table 1: Contingency table of ESRD versus gender 
Gender 
ESRD 
Total (%) 
No Yes 
Female 104 59 163 (40) 
Male 136 108 244 (60) 
Total (%) 240 (59) 167 (41) 407 
 
 The odds of ESRD show that the males are 
1.4 times more exposed to ESRD than the females 
and the Log of the odds ratio is 0.336 (with a standard 
error = 0.208). The confidence interval for the odds 
ratio is (0.931, 2.104) at the 5% level of significance. 
The interval contains unity; it indicates independence 
(no association between Gender and ESRD). Also, p-
value is greater than 0.05, the result is insignificant. It 
is concluded that there is no association between 
Gender and ESRD.  
 
ESRD versus diabetic 
Contingency table of ESRD versus diabetic is 
given in Table 2. The calculated values are: Odd Ratio 
= 11.04, Chi-square = 141.883, p-value < 0.001 and 
the confidence interval is (6.913, 17.63). 
Table 2: Contingency table of ESRD versus diabetic 
Diabetic 
ESRD 
Total (%) 
No Yes 
No  185 39 224 (55) 
Yes  55 128 183 (45) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the diabetic 
patients are 11.04 times more exposed to ESRD than 
the non-diabetic patients and the Log of odds ratio is 
2.402 (with a standard error = 0.239). The confidence 
interval for the odds ratio is (6.913, 17.63) at the 5% 
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level of significance. The interval does not contain 
unity; it indicates that there is an association between 
Diabetic and ESRD. Also, observed p-value is less 
than 0.05, the result is significant. It is concluded that 
there is a strong association between diabetes and 
ESRD.  
 
ESRD versus hypertension 
Contingency table of ESRD versus 
hypertension is given in Table 3. The calculated 
values are: Odd Ratio = 7.287, Chi-square = 77.56, p-
value < 0.001 and the confidence interval is (4.571, 
11.616). 
Table 3: Contingency table of ESRD versus hypertension 
Hypertension 
ESRD 
Total (%) 
No Yes 
No  152 32 184 (45) 
Yes  88 135 233 (55) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the 
hypertensive patients are 7.287 times more exposed 
to ESRD than the non-hypertensive patients and the 
Log of odds ratio is 1.986 (with a standard error = 
0.238). The confidence interval for the odds ratio is 
(4.571, 11.616) at the 5% level of significance. The 
interval does not contain unity; it indicates there is an 
association between hypertension and ESRD. Also, 
observed p-value is less than 0.05, the result is 
significant. It is concluded that there is a strong 
association between hypertension and ESRD.  
 
ESRD versus glomerulonephritis 
Contingency table of ESRD versus 
glomerulonephritis is given in Table 4. The calculated 
values are: Odd Ratio = 3.115, Chi-square = 29.826, 
p-value < 0.001 and the confidence interval is (2.059, 
4.712). 
Table 4: Contingency table of ESRD versus glomerulonephritis 
Glomerulonephritis ESRD  
Total (%) No Yes 
No  171 74 245 (60) 
Yes  69 93 162 (40) 
Total (%) 240 (59) 167 (41) 407 
  
The odds of ESRD show that the 
glomerulonephritis patients are 3.115 times more 
exposed to ESRD than the non-glomerulonephritis 
patients and the Log of odds ratio is 1.136 (with a 
standard error = 0.211). The confidence interval for 
the odds ratio is (2.059, 4.712) at the 5% level of 
significance. The interval does not contain unity; it 
indicates there is association between 
glomerulonephritis and ESRD. Also, observed p-value 
is less than 0.05, the result is significant. It is 
concluded that there is a strong association between 
glomerulonephritis and ESRD.  
ESRD versus obstructive nephropathy 
Contingency table of ESRD versus 
obstructive nephropathy is given in Table 5. The 
calculated values are: Odd Ratio = 1.2, Chi-square = 
0.542, p-value = 0.462 and the confidence interval is 
(0.738, 1.952). 
Table 5: Contingency table of ESRD versus obstructive 
nephropathy 
Obstructive 
Nephropathy 
ESRD 
Total (%) 
No Yes 
No  194 130 324 (80) 
Yes  46 37 83 (20) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the obstructive 
nephropathy patients are 1.2 times more exposed to 
ESRD than the non-obstructive nephropathy patients 
and the Log of odds ratio is 0.182 (with standard error 
= 0.248). The confidence interval for the odds ratio is 
(0.738, 1.952) at the 5% level of significance. The 
interval contains unity; it indicates independence. 
Also, observed p-value is greater than 0.05, the result 
is insignificant. It is concluded that there is no 
association between obstructive nephropathy and 
ESRD.  
 
ESRD versus polycystic kidney disease 
Contingency table of ESRD versus Polycystic 
kidney is given in Table 6. The calculated values are: 
Odd Ratio = 1.67, Chi-square = 0.186, p-value = 
0.403 and Confidence Interval is (0.553, 2.527). 
Table 6: Contingency table of ESRD versus polycystic kidney 
disease 
APKD ESRD 
Total (%) 
No Yes 
No  224 154 378 (93) 
Yes  16 13 29 (7) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the patients, 
who had Polycystic kidney disease, are 1.67 times 
more exposed to ESRD than the patients who do not 
have Polycystic kidney disease and the Log of odds 
ratio is 0.167 (with standard error = 0.288). The 
confidence interval for the odds ratio is (0.553, 2.527) 
at the 5% level of significance. The interval contains 
unity; it indicates independence. Also, observed p-
value is greater than 0.05, the result is insignificant. It 
is concluded that there is no association between 
polycystic kidneydisease and ESRD. 
 
ESRD versus myeloma 
Contingency table of ESRD versus myeloma 
is given in Table 7. The calculated values are: Odd 
Ratio = 1.081, Chi-square = 0.20, p-value = 1.000 and 
Confidence Interval is (0.368, 3.174). 
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Table 7: Contingency table of ESRD verses myeloma 
Myeloma ESRD 
Total (%) 
No Yes 
No  232 161 393 (97) 
Yes  8 6 14 (3) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the myeloma 
patients are 1.081 times more exposed to ESRD than 
the non-myeloma patients and the Log of odds ratio is 
0.078 (with a standard error = 0.302). The confidence 
interval for the odds ratio is (0.368, 3.174) at the 5% 
level of significance. The interval contains unity; it 
indicates independence. Also, observed p-value is 
greater than 0.05, the result is insignificant. It is 
concluded that there is no association between 
myeloma and ESRD. 
 
ESRD versus SLE nephritis 
Contingency table of ESRD versus SLE 
nephritis is given in Table 8. The calculated values 
are: Odd Ratio = 1.132, Chi-square = 0.051, p-value = 
0.802 and Confidence Interval is (0.41, 3.077). 
Table 8: Contingency table of ESRD versus SLE nephritis 
SLE Nephritis ESRD 
Total (%) 
No Yes 
No  231 160 391 (96) 
Yes  9 7 16 (4) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the SLE nephritis 
patients are 1.123 times more exposed to ESRD than 
the non-SLE nephritis patients and the Log of odds 
ratio is 0.116 (with standard error = 0.551). The 
confidence interval for the odds ratio is (0.41, 3.077) 
at the 5% level of significance. The interval contains 
unity; it indicates independence. Also, observed p-
value is greater than 0.05, the result is insignificant. It 
is concluded that there is no association between SLE 
nephritis and ESRD.  
 
ESRD versus heredity 
Contingency table of ESRD versus heredity is 
given in Table 9. The calculated values are: Odd Ratio 
= 1.757, Chi-square = 1.818, p-value = 0.202 and 
Confidence Interval is (0.767, 4.024). 
Table 9: Contingency table of ESRD versus heredity 
Heredity ESRD 
Total (%) 
No Yes 
No  229 154 383 (94) 
Yes  11 13 24 (6) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the patients, 
who have a family history of ESRD, are 1.757 times 
more exposed to ESRD than the patients who do not 
have a family history of ESRD and the Log of odds 
ratio is 0.564 (with standard error = 0.423). The 
confidence interval for the odds ratio is (0.767, 4.024) 
at the 5% level of significance. The interval contains 
unity; it indicates independence. Also, p-value is 
greater than 0.05, the result is insignificant. It is 
concluded that there is no association between 
heredity and ESRD.  
 
ESRD versus hepatitis 
Contingency table of ESRD versus hepatitis is 
given in Table 10. The calculated values are: Odd 
Ratio = 1.792, Chi-square = 4.495, p-value = 0.063 
and Confidence Interval is (0.747, 2.277). 
Table 10: Contingency table of ESRD versus hepatitis  
Hepatitis ESRD 
 Total (%) 
No  Yes  
No  211 134  345 (85) 
Yes   29  33  62 (15) 
Total (%) 240 (59) 167 (41)  407 
 
The odds of ESRD show that the hepatitis 
patients are 1.792 times more exposed to ESRD than 
the non-hepatitis patients and the Log of odds ratio is 
0.253 (with a standard error = 0.277). The confidence 
interval for the odds ratio is (0.747, 2.277) at the 5 % 
level of significance. The interval contains unity; it 
indicates independence. Also, observed p-value is 
greater than 0.05, the result is insignificant. It is 
concluded that there is no association between 
hepatitis and ESRD.  
 
ESRD versus drug usage 
Contingency table of ESRD versus drug 
usage is given in Table 11. The calculated values are: 
Odd Ratio = 1.157, Chi-square = 0.091, p-value = 
0.809 and Confidence Interval is (0.100, 2.994). 
Table 11: Contingency table of ESRD versus drug usage 
Hepatitis ESRD 
Total (%) 
No Yes 
No  230 159 389 (96) 
Yes  10 8 18 (4) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the patients, 
who used a lot of drugs, are 1.157 times more 
exposed to ESRD than the patients who do not use a 
lot of drugs and the Log of odds ratio is 0.146 (with 
standard error = 0.485). The confidence interval for 
the odds ratio is (0.100, 2.994) at the 5% level of 
significance. The interval contains unity; it indicates 
independence. Also, observed p-value is greater than 
0.05, the result is insignificant. It is concluded that 
there is no association between drug usage and 
ESRD.  
 
ESRD versus heart problem 
Contingency table of ESRD versus heart 
problem is given in Table 12. The calculated values 
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are: Odd Ratio = 1.15, Chi-square = 0.0243, p-value = 
0.672 and Confidence Interval is (0.100, 2.994). 
Table 12: Contingency table of ESRD verses heart problem 
Heart Problem ESRD 
Total (%) 
No Yes 
No  227 156 383 (94) 
Yes  13 11 24 (6) 
Total (%) 240 (59) 167 (41) 407 
 
The odds of ESRD show that the patients who 
have heart problem are 1.231 times more exposed to 
ESRD than the patients who do not have heart 
problems and the Log of the odds ratio is 0.208 (with 
standard error = 0.422). The confidence interval for 
the odds ratio is (0.543, 2.285) at the 5% level of 
significance. The interval contains unity; it indicates 
independence. Also, observed p-value is greater than 
0.05, the result is insignificant. It is concluded that 
there is no association between heart problem and 
ESRD.  
 
ESRD versus anemia 
Contingency table of ESRD versus anemia is 
given in Table 13. The calculated values are: Odd 
Ratio = 1.083, Chi-square = 0.088, p-value = 0.788 
and Confidence Interval is (0.676, 4.024). 
The odds of ESRD show that the anemia, 
patients are 1.083 times more exposed to ESRD than 
the non-anemia patients and the Log of odds ratio is 
0.080 (with a standard error = 0.269). The confidence 
interval for the odds ratio is (0.767, 4.024) at the 5 % 
level of significance.  
Table 13: Contingency тable of ESRD verses anemia 
Anemia ESRD 
 Total (%) 
No  Yes  
No  201 138  339 (83) 
Yes   39  29  68 (17) 
Total (%) 240 (59) 167 (41)  407 
 
The interval contains unity; it indicates 
independence. Also, observed p-value is greater than 
0.05, the result is insignificant. It is concluded that 
there is no association between anemia and ESRD.  
 
 
Discussion 
 
The major aim of this study was to determine 
the most important risk factors of ESRD in Peshawar. 
A total of 407 patients was examined in the three 
major hospitals of Peshawar and the phenomena of 
ESRD was studied in relation to different risk factors 
like diabetic, hypertension, glomerulonephritis, 
obstructive nephropathy, polycystic kidney diseases, 
myeloma, SLE nephritis, heredity, hepatitis, excess 
use of drugs, heart problem and anemia. 
Out of 407 patients, 244 (60%) were males 
and 163 (40%) were females. The average age of 
male patients was 43.38 years and the average age of 
female patients was 42.4 years. Out of 244 male 
patients, 108 patients were in an uncontrolled group 
(ESRD cases) and out of 163 female patients, 59 
were in an uncontrolled group (ESRD cases). 
The total number of diabetic patients was 183 
in which 128 patients had ESRD. On the other hand, 
out of 185 non-diabetic patients, 39 patients had 
ESRD. The total number of 233 (55%) patients had 
hypertension in which 135 (60.5%) had ESRD and out 
of 184 non-hypertension patients, 32 patients had 
ESRD. A total of 162 patients had glomerulonephritis 
in which 93 (57.4%), patients had ESRD and 74 
patients out of 240 non-glomerulonephritis patients, 
had ESRD. The total number of 62 patients had 
hepatitis, in which 33 patients had ESRD and 134 
patients out of 345 non-hepatitis patients, had ESRD. 
The total number of 83 patients had 
obstructive nephropathy problem in which 37 patients 
had ESRD. On the other hand, 120 patients out of 324 
non-obstructive nephropathy patients had ESRD. The 
total number of 29 patients had polycystic kidney 
disease problem in which 13 have ESRD. On the 
other hand, 154 patients out of 324 non-polycystic 
kidney disease patients had ESRD. There were 14 
myeloma patients out of 407, in which 6 patients had 
ESRD. On the other hand, 161 patients out of 378 
non-myeloma patients had ESRD. There were 16 SLE 
nephropathy patients out of 407, in which 7 had 
ESRD. On the other hand, 160 patients out of 393 
non-SLE nephropathy patients had ESRD. A total of 
13 patients out of 24 patients had a family history of 
ESRD. On the other hand, 154 patients out of 389 
non-heredity patients had ESRD. There were 18 
patients who used a lot of drugs in which 8 patients 
had ESRD. On the other hand, 159 patients out of 384 
non-drug user had ESRD. A total of 24 patients had 
heart problems in which 11 had ESRD. On the other 
hand, out of 383 non-heart problem patients, 156 
patients had ESRD. Out of 68 anemic patients, 29 
patients had ESRD. On the other hand, 138 patients 
out of 339 non-anemia patients had ESRD. 
Using odds ratio analysis, it was found that 
the ESRD in diabetic patients were 11.04 times more 
than non-diabetic patients and the ESRD in 
hypertensive patients were 7.29 times more than non-
hypertensive patients. Similarly, glomerulonephritis 
patients have 3.115 times more chances to have 
ESRD than non-glomerulonephritis. This analysis 
shows that there was a strong association between 
ESRD and the three risk factors diabetes, 
hypertension and glomerulonephritis. The odds of 
ESRD for heredity were 1.76 times more than non-
heredity patients. The odds of ESRD for non-hepatitis 
patients were 1.792 times less than hepatitis patients. 
Based on odds ratio analysis, using data from 
407 patients from three major hospitals of Peshawar, 
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the researchers concluded that the main causes of 
ESRD were the three risk factors i.e. diabetes, 
hypertension and glomerulonephritis. Other risk 
factors, i.e. obstructive nephropathy, heredity and 
hepatitis may also, to some extent, causes of ESRD 
but in this study, it turned out to be insignificant due to 
stochastic sample.  
The researchers concluded that the main 
finding of this study is that there is a strong 
association between ESRD and the three risk factors 
namely diabetic, hypertension & glomerulonephritis. 
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